Abstract Number: 948 • 2012 ACR/ARHP Annual Meeting
Antibody-Based Prediction Rules for Connective Tissue Disease: Analysis of 12,555 Patients with Antinuclear Antibody Testing
Background/Purpose: Antinuclear antibody (ANA) is widely used as a screening test for connective tissue diseases (CTDs). The sensitivity of this test is high in 3…Abstract Number: 949 • 2012 ACR/ARHP Annual Meeting
The Inverse Association Between Obesity and Anti-Nuclear Antibodies Is Modified by Systemic Inflammation and Maybe Associated with Body Composition
Background/Purpose: Obesity and abdominal adiposity have been frequently associated with inflammation. However, an association of obesity with a decreased likelihood of anti-nuclear antibodies (ANAs) was…Abstract Number: 950 • 2012 ACR/ARHP Annual Meeting
Performance of Various Anti-Nuclear Antibody Methodologies in the Assessment of Autoimmune Connective Tissue Diseases
Background/Purpose : The anti-nuclear antibody (ANA) is the classic biomarker associated with autoimmune connective tissue diseases (CTDs). ANA testing is often ordered as part of…Abstract Number: 951 • 2012 ACR/ARHP Annual Meeting
A Systematic Review of Quality of Prognosis Studies in Systemic Lupus Erythematosus
Background/Purpose: Prognosis studies study future outcomes and/or seek to identify predictive or associative factors associated with outcomes. Strong and consistent prognostic factors can be used…Abstract Number: 952 • 2012 ACR/ARHP Annual Meeting
Cognitive Behavioral Therapy and Milnacipran in Combination Appears to Be More Efficacious Than Either Therapy Alone
Background/Purpose: The two treatment options that have received the significant attention in fibromyalgia (FM) management are cognitive behavioral therapy (CBT) and medications. Given the fact…Abstract Number: 953 • 2012 ACR/ARHP Annual Meeting
Comparative Symptom Severity of Patients Satisfying Chronic Widespread Pain and Fibromyalgia Criteria
Background/Purpose: Chronic widespread pain (CWP) is often used as a surrogate for fibromyalgia in epidemiological research, particularly in Europe and in whiplash-related injuries. This CWP…Abstract Number: 914 • 2012 ACR/ARHP Annual Meeting
Prognosis for the Year 2030: The Consultation Prevalence of Osteoarthritis in Sweden May Increase by 50%
Background/Purpose: To project the future prevalence of knee and hip osteoarthritis (OA) leading to doctor consultation. Methods: The Skåne Health Care Register is a legislative,…Abstract Number: 915 • 2012 ACR/ARHP Annual Meeting
Incidence of Knee, Hip, and Hand Clinical Osteoarthritis: A Population-Based Cohort Study
TITLE: "Incidence of knee, hip, and hand clinical osteoarthritis: a population-based cohort study."AUTHORS: Daniel Prieto-Alhambra*, Aina Pag�s-Castellˆ, M Kassim Javaid, Andrew Judge, Cyrus Cooper, Nigel…Abstract Number: 916 • 2012 ACR/ARHP Annual Meeting
Population Incidence of Soft Tissue Knee Injury: Estimates From a Swedish Health Care Register
Background/Purpose: Soft tissue knee injury is a well-established and potent risk factor for development of knee osteoarthritis. However, there is a paucity of epidemiological data…Abstract Number: 917 • 2012 ACR/ARHP Annual Meeting
Feasibility of Remote Activity and Functional Status Monitoring of Patients with Hip or Knee Pain
Background/Purpose: The incidence of total hip and knee arthroplasties has risen over the past decade and by 2030, the demand of these arthroplasties is estimated…Abstract Number: 918 • 2012 ACR/ARHP Annual Meeting
Impact of Comorbidities On Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis
Background/Purpose: Comorbidities refer to chronic co-occuring disorders and are inversely and negatively correlated with HRQoL. Because indirect utility measurement involves HRQoL, comorbidities probably affect utility…Abstract Number: 919 • 2012 ACR/ARHP Annual Meeting
Sedentary Time, Physical Activity, and Concurrent Blood Pressure in Osteoarthritis Initiative Participants
Background/Purpose: The inactivity physiology hypothesis suggests that sedentarism is a cardiovascular risk factor independent of time spent in moderate-vigorous activity (MV). Previous research suggests that…Abstract Number: 920 • 2012 ACR/ARHP Annual Meeting
A Multimodal Intervention to Improve Osteoporosis Care in Home Health Settings: Results From a Cluster Randomized Trial
Background/Purpose: Although very effective osteoporosis treatments are available, the rates of use are low, even among individuals who have already experienced a fracture and are…Abstract Number: 921 • 2012 ACR/ARHP Annual Meeting
Association Between Metabolic Syndrome and Bone Mineral Density in a Community-Dwelling Older Women: The São Paulo Ageing & Health Study (SPAH)
Background/Purpose: Recent studies have shown a link between metabolic syndrome (MS) and bone mass. However, these results are uncertain about the positive/negative effect of the…Abstract Number: 922 • 2012 ACR/ARHP Annual Meeting
Risk of Fracture Among Treated and Untreated Men with Osteoporosis
Background/Purpose: Osteoporosis (OP) affects an estimated 2 million men in the United States. The relationship between treatment and fracture outcomes has been reported from clinical…